At #ESMO2026 in Madrid, Prof. Herbert H. Loong emphasized that the future of precision oncology depends on three key elements: Precision, Speed, and Access.

He highlighted how multi-omic liquid biopsy approaches can complement tissue testing, support MRD detection, monitor treatment response, and potentially make precision oncology more accessible and sustainable.

Precision oncology is not just about identifying the right treatment, but delivering it at the right time to more patients.

#ESMO2026 #LiquidBiopsy @oncodaily #PrecisionOncology #MultiOmics @herbloong